ReP USP - Resultado da busca

Artigo de periodico
Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius (2021)
Oliveira, Nayana Keyla Seabra de; Almeida, Marcos Rafael Silva; Pontes, Franco Márcio Maciel; Barcelos, Mariana Pegrucci ; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Cruz, Rodrigo Alves Soares; Melim, Lorane Izabel da Silva Hage
Source: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Subjects: AÇAÍ, FLAVONOIDES, ANTIOXIDANTES, POLIFENÓIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Nayana Keyla Seabra de et al. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius. Current Computer-Aided Drug Design, v. 17, n. 4, p. 589-617, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573409916666200619122803. Acesso em: 13 jun. 2024.
APA
Oliveira, N. K. S. de, Almeida, M. R. S., Pontes, F. M. M., Barcelos, M. P., Silva, G. M. da, Silva, C. H. T. de P. da, et al. (2021). Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius. Current Computer-Aided Drug Design, 17( 4), 589-617. doi:10.2174/1573409916666200619122803
NLM
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva GM da, Silva CHT de P da, Cruz RAS, Melim LI da SH. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius [Internet]. Current Computer-Aided Drug Design. 2021 ; 17( 4): 589-617.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1573409916666200619122803
Vancouver
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva GM da, Silva CHT de P da, Cruz RAS, Melim LI da SH. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius [Internet]. Current Computer-Aided Drug Design. 2021 ; 17( 4): 589-617.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1573409916666200619122803
Artigo de periodico
Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease (2020)
Souza, Lucilene R.; Picanço, Leide C. S.; Brito, Maiara F. B.; Almeida, Marcos R. S.; Marino, Bianca L. B.; Sousa, Kessia P. A.; Ferreira, Jaderson V.; Santos, Cleydson B. R.; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Taft, Carlton A.; Melim, Lorane Izabel da Silva Hage
Source: Central Nervous System Agents in Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Subjects: FARMACOCINÉTICA, DOENÇA DE PARKINSON, PLANEJAMENTO DE FÁRMACOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL), RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Lucilene R. et al. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, v. 20, n. 2, p. 128-143, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871524920666200217110211. Acesso em: 13 jun. 2024.
APA
Souza, L. R., Picanço, L. C. S., Brito, M. F. B., Almeida, M. R. S., Marino, B. L. B., Sousa, K. P. A., et al. (2020). Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, 20( 2), 128-143. doi:10.2174/1871524920666200217110211
NLM
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Vancouver
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Artigo de periodico
Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study (2020)
Castro, Leandro L.; Picanço, Leide C. S.; Silva, Jaderson V.; Souza, Lucilene R.; Sousa, Kessia P. A.; Pinheiro, Abraão A.; Chaves, Gisele A.; Teixeira, Hueldem R. C.; Silva, Guilherme Martins da ; Taft, Carlton A.; Silva, Carlos Henrique Tomich de Paula da ; Melim, Lorane Izabel da Silva Hage
Source: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Subjects: DOENÇA DE ALZHEIMER, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Leandro L. et al. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, v. 16, n. 5, p. 541-554, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573409915666191015110734. Acesso em: 13 jun. 2024.
APA
Castro, L. L., Picanço, L. C. S., Silva, J. V., Souza, L. R., Sousa, K. P. A., Pinheiro, A. A., et al. (2020). Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, 16( 5), 541-554. doi:10.2174/1573409915666191015110734
NLM
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1573409915666191015110734
Vancouver
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 jun. 13 ] Available from: https://doi.org/10.2174/1573409915666191015110734

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em